LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 26

Search options

  1. Book ; Thesis: Klinische Anwendungsmöglichkeiten der digitalen Subtraktionsangiographie bei perkutaner transluminaler Angioplastie der Extremitäten- und Nierengefäße

    Lauterbach, Thomas

    1984  

    Size 129 S. : Ill.
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Frankfurt (Main), Univ., Diss., 1985
    HBZ-ID HT003237341
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  2. Book: Digital audio broadcasting

    Hoeg, Wolfgang / Lauterbach, Thomas

    principles and applications of DAB, DAB+ and DMB

    2009  

    Author's details eds. Wolfgang Hoeg and Thomas Lauterbach
    Keywords Digital audio broadcasting
    Language English
    Size XXXII, 420 S., Ill., graph. Darst., Kt.
    Edition 3. ed.
    Publisher Wiley
    Publishing place Chichester
    Document type Book
    Note Literaturverz. S. [395] - 411
    ISBN 9780470510377 ; 0470510374
    Database Library catalogue of the German National Library of Science and Technology (TIB), Hannover

    More links

    Kategorien

  3. Book: Schlußbericht über die Arbeiten zu Digital Audio Broadcasting (EU 147)

    Lauterbach, Thomas

    Entwicklung eines Labormusters für einen DAB-Empfänger und Felderprobung des Gesamtsystems, [Abschlußdatum des Vorhabens: Dezember 1994]

    1995  

    Institution Robert Bosch GmbH
    Author's details Robert Bosch GmbH. Projektleiter: Thomas Lauterbach
    Language German
    Size Getr. Zählung, Ill., graph. Darst
    Publishing place Hildesheim
    Document type Book
    Note Die Vorlage enth. insgesamt 3 Werke ; Förderkennzeichen BMFT 01BK201B9
    Database Library catalogue of the German National Library of Science and Technology (TIB), Hannover

    More links

    Kategorien

  4. Book: 1000 Konstruktionsbeispiele für die Praxis

    Krahn, Heinrich / Eh, Dieter / Lauterbach, Thomas

    2010  

    Title variant Tausend Konstruktionsbeispiele für die Praxis
    Author's details Heinrich Krahn; Dieter Eh; Thomas Lauterbach
    Keywords Maschinenbau ; Konstruktion
    Language German
    Size XL, 495 S, Ill., graph. Darst., 26,5 cm
    Edition 3., erw. Aufl
    Publisher Hanser
    Publishing place München u.a.
    Document type Book
    Note Literaturverz. S. 461 - 463
    Accompanying material 1 DVD-ROM (12 cm)
    ISBN 3446420347 ; 9783446420342
    Database Library catalogue of the German National Library of Science and Technology (TIB), Hannover

    More links

    Kategorien

  5. Article ; Online: Reduction of gastrointestinal symptoms in Parkinson's disease after a switch from oral therapy to rotigotine transdermal patch: a non-interventional prospective multicenter trial.

    Woitalla, Dirk / Kassubek, Jan / Timmermann, Lars / Lauterbach, Thomas / Berkels, Reinhard / Grieger, Frank / Müller, Thomas

    Parkinsonism & related disorders

    2015  Volume 21, Issue 3, Page(s) 199–204

    Abstract: Introduction: Gastrointestinal (GI) symptoms are common among patients with Parkinson's disease (PD), due to both the disease itself and anti-PD drugs. We hypothesized that transdermal drug administration may result in fewer GI problems. This ... ...

    Abstract Introduction: Gastrointestinal (GI) symptoms are common among patients with Parkinson's disease (PD), due to both the disease itself and anti-PD drugs. We hypothesized that transdermal drug administration may result in fewer GI problems. This prospective observational study (ClinicalTrials.gov: NCT01159691) investigated effect of switching to rotigotine transdermal patch from oral anti-PD medications in patients with PD and existing GI symptoms.
    Methods: Patients were enrolled if their physician was planning to switch them to rotigotine because of GI symptoms experienced while receiving oral anti-PD medications. Effectiveness assessments included a visual analog scale (VAS) measuring intensity of GI symptoms from 0 (no disorder) to 100 mm (extremely severe disorder), a questionnaire on the frequency and intensity of six individual GI complaints (heartburn, bloating, nausea, vomiting, abdominal pain, diarrhea), each rated 0-12 for a sum score of 0-72, and patient satisfaction regarding GI symptoms over approximately 6 weeks after switching.
    Results: Of 75 patients who received rotigotine, 58 had follow-up data available for final analysis. Intensity of GI complaints improved numerically on both the VAS (47.5 ± 24.4 mm [n = 65] at baseline, 19.7 ± 23.3 mm [n = 58] after around 6 weeks) and the sum score of GI complaints (11.2 ± 9.0 at baseline, 2.1 ± 4.4 [n = 58] after around 6 weeks). Fifty of 58 patients were "satisfied" or "very satisfied" regarding GI symptoms over around 6 weeks following switch to the patch.
    Conclusion: This study suggests that a switch from oral anti-PD medications to rotigotine transdermal patch may improve existing GI symptoms among patients with PD. Additional controlled studies are needed to confirm this finding.
    MeSH term(s) Administration, Oral ; Aged ; Aged, 80 and over ; Antiparkinson Agents/administration & dosage ; Female ; Follow-Up Studies ; Gastrointestinal Diseases/drug therapy ; Gastrointestinal Diseases/etiology ; Humans ; Male ; Middle Aged ; Pain Measurement ; Parkinson Disease/complications ; Parkinson Disease/drug therapy ; Patient Satisfaction ; Tetrahydronaphthalenes/administration & dosage ; Thiophenes/administration & dosage ; Transdermal Patch
    Chemical Substances Antiparkinson Agents ; Tetrahydronaphthalenes ; Thiophenes ; rotigotine (87T4T8BO2E)
    Language English
    Publishing date 2015-03
    Publishing country England
    Document type Clinical Trial ; Journal Article ; Multicenter Study ; Observational Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 1311489-x
    ISSN 1873-5126 ; 1353-8020
    ISSN (online) 1873-5126
    ISSN 1353-8020
    DOI 10.1016/j.parkreldis.2014.11.024
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Patients' perception of Parkinson's disease-associated pain following initiation of rotigotine: a multicenter non-interventional study.

    Timmermann, Lars / Oehlwein, Christian / Ransmayr, Gerhard / Fröhlich, Holger / Will, Edgar / Schroeder, Hanna / Lauterbach, Thomas / Bauer, Lars / Kassubek, Jan

    Postgraduate medicine

    2017  Volume 129, Issue 1, Page(s) 46–54

    Abstract: Objectives: To evaluate Parkinson's disease (PD)-associated pain as perceived by the patients (subjective characterization), and how this may change following initiation of rotigotine transdermal patch.: Methods: SP1058 was a non-interventional study ...

    Abstract Objectives: To evaluate Parkinson's disease (PD)-associated pain as perceived by the patients (subjective characterization), and how this may change following initiation of rotigotine transdermal patch.
    Methods: SP1058 was a non-interventional study conducted in routine clinical practice in Germany and Austria in patients experiencing PD-associated pain (per the physician's assessment). Data were collected at baseline (ie, before rotigotine initiation) and at a routine visit after ≥25 days (-3 days allowed) of treatment on a maintenance dose of rotigotine (end of study [EoS]). Pain perception was assessed using the 12-item Pain Description List of the validated German Pain Questionnaire (each item ranked 0 = 'not true' to 3 = 'very true'). Primary effectiveness variable: change from baseline to EoS in the sum score of the 4 'affective dimension' items of the Pain Description List. Secondary effectiveness variables: change from baseline to EoS in Unified Parkinson's Disease Rating Scale (UPDRS) II, III, and II+III scores, and Parkinson's Disease Questionnaire (PDQ-8) total score (PD-related quality-of-life). Other variables included scores of the eight 'sensory dimension' items of the Pain Description List.
    Results: Of 93 enrolled patients (mean [SD] age: 71.1 [9.0] years; male: 48 [52%]), 77 (83%) completed the study, and 70 comprised the full analysis set. The mean (SD) change from baseline in the sum score of the four 'affective dimension' items was -1.3 (2.8) indicating a numerical improvement (baseline: 3.9 [3.4]). In the 'sensory dimension', pain was mostly perceived as 'pulling' at baseline (49/70 [70%]); 'largely true'/'very true'). Numerical improvements were observed in all UPDRS scores (mean [SD] change in UPDRS II+III: -5.3 [10.5]; baseline: 36.0 [15.9]), and in PDQ-8 total score (-2.0 [4.8]; baseline: 10.7 [5.9]). Adverse drug reactions were consistent with dopaminergic stimulation and transdermal administration.
    Conclusion: The perception of the 'affective dimension' of PD-associated pain numerically improved in patients treated with rotigotine. ClinicalTrials.gov identifier: NCT01606670; https://clinicaltrials.gov/ct2/show/NCT01606670?term=NCT01606670&rank=1.
    MeSH term(s) Activities of Daily Living ; Administration, Cutaneous ; Aged ; Aged, 80 and over ; Austria ; Dopamine Agonists/therapeutic use ; Female ; Follow-Up Studies ; Germany ; Humans ; Male ; Middle Aged ; Pain/drug therapy ; Pain/etiology ; Parkinson Disease/complications ; Surveys and Questionnaires ; Tetrahydronaphthalenes/therapeutic use ; Thiophenes/therapeutic use
    Chemical Substances Dopamine Agonists ; Tetrahydronaphthalenes ; Thiophenes ; rotigotine (87T4T8BO2E)
    Language English
    Publishing date 2017-01
    Publishing country England
    Document type Clinical Trial ; Comparative Study ; Journal Article ; Multicenter Study ; Observational Study
    ZDB-ID 410138-8
    ISSN 1941-9260 ; 0032-5481
    ISSN (online) 1941-9260
    ISSN 0032-5481
    DOI 10.1080/00325481.2017.1258953
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Conference proceedings ; Online: Empirical study on implicit polarization diversity and space diversity for short range indoor-to-outdoor radio links below 1 GHz

    Rauh, Sebastian / Lauterbach, Thomas / Lieske, Hendrik / Kilian, Gerd / Robert, Jörg / Heuberger, Albert

    2017  

    Abstract: 9 S. ... To assess the properties of short-range indoor-tooutdoor radio channels for applications like telemetry and smart metering we performed several field trials. They were operated in urban and commercial areas for several weeks each. Multiantenna ... ...

    Abstract 9 S.

    To assess the properties of short-range indoor-tooutdoor radio channels for applications like telemetry and smart metering we performed several field trials. They were operated in urban and commercial areas for several weeks each. Multiantenna receivers were used to record signal levels from two different antennas in parallel. Due to multipath propagation, in some of the channels low signal levels were observed. We therefore investigated if diversity techniques can be applied to improve reception, focussing on implicit polarization diversity and space diversity. From measurements over long time periods we derived the distributions of correlation coefficients and signal levels obtained from more than 80 radio links each using 3, 7 and 27 channels in the 169 MHz, 434 MHz and 868 MHz bands, respectively. For implicit polarization diversity and space diversity with horizontal spacing of antennas of one to six wavelengths we find the signals from the two antennas to be sufficiently decorrelated (correlation coefficents < 0.7) for most of the radio links and channels. In contrast, for space diversity with two antennas placed on the same mast at different heights, in many cases the signals were not sufficiently decorrelated. With respect to cross-polarization imbalance, we find values between -3 dB and 9 dB in the different trials and in the different frequency bands. The results show that generally both diversity schemes have the potential to significantly improve the performance of short range indoor-to-outdoor radio transmission systems. If space diversity with two vertically polarized antennas is not feasible due to lack of a second antenna mast, implicit polarization diversity will perform well, in particular if the imbalance of signal levels can be compensated e.g. by using a cross-polarized antenna with appropriately higher gain.
    Keywords Nachrichtentechnik
    Subject code 621
    Language English
    Publishing country de
    Document type Conference proceedings ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article: Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice.

    Reinhardt, Fritjof / Weber, Yvonne G / Mayer, Thomas / Luef, Gerhard / Joeres, Lars / Tennigkeit, Frank / Dedeken, Peter / De Backer, Marc / Hellot, Scarlett / Lauterbach, Thomas / Webers, Tanja / Arnold, Stephan

    Epilepsia open

    2019  Volume 4, Issue 3, Page(s) 409–419

    Abstract: Introduction: Effects of antiepileptic drug (AED) load changes in patients with focal seizures have not been well evaluated.: Methods: SP1065 (NCT01673282) was a noninterventional, prospective, observational study conducted in a clinical practice ... ...

    Abstract Introduction: Effects of antiepileptic drug (AED) load changes in patients with focal seizures have not been well evaluated.
    Methods: SP1065 (NCT01673282) was a noninterventional, prospective, observational study conducted in a clinical practice setting. Patients (aged ≥18 years) with focal seizures were enrolled within 7 days of being prescribed adjunctive lacosamide. Observation period was ~6 months. Drug load was assessed using percentage change in ratio of actual prescribed dose and World Health Organization defined daily dose (DDD) for concomitant AEDs and all AEDs (including lacosamide). Subgroups were defined for patients with at least one concomitant sodium channel-blocking AED (SCB [+]) and those without (SCB [-]).
    Results: A total of 311 patients were assessed for safety, 302 for measurement of drug load, and 240 for effectiveness. Ratio of AED dose to DDD decreased for concomitant AEDs (-9.6%) and increased for all AEDs (including lacosamide; 15.5%). Median reduction in focal seizure frequency per 28 days was 100% (range: -100, 2275.8). 70.4% and 61.7% of patients had a ≥50% or ≥75% reduction in seizure frequency, respectively; 50.8% became seizure-free. In the SCB (+) subgroup (n = 149), ratio of AED dose to DDD decreased for concomitant AEDs (-15.0%) and increased for all AEDs (10.7%). In the SCB (-) subgroup (n = 153), ratio of AED dose to DDD decreased for concomitant AEDs (-4.4%) and increased for all AEDs (20.2%). Fifty-seven patients (18.3%) reported ADRs, most commonly dose >400 mg/d (7.1%). Seventeen patients (5.5%) had ADRs leading to discontinuation.
    Significance: Addition of lacosamide resulted in reduction of concomitant AED drug load regardless of whether concomitant AEDs were SCB (+) or SCB (-). These results indicate that addition of lacosamide in patients with focal seizures could allow clinicians to withdraw or reduce the dose of less well-tolerated or less effective AEDs.
    Language English
    Publishing date 2019-06-22
    Publishing country United States
    Document type Journal Article
    ISSN 2470-9239
    ISSN 2470-9239
    DOI 10.1002/epi4.12346
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Book: 1000 Konstruktionsbeispiele für die Praxis

    Krahn, Heinrich / Eh, Dieter / Lauterbach, Thomas

    2007  

    Title variant tausend eintausend
    Author's details Heinrich Krahn; Dieter Eh; Thomas Lauterbach
    Keywords Maschinenbau ; Konstruktion
    Language German ; English
    Size XL, 463 S., zahlr. graph. Darst.
    Edition 2., [erw.] Aufl.
    Publisher Hanser
    Publishing place München u.a.
    Document type Book
    Note Literaturverz. S. 429 - 431
    Accompanying material 1 DVD-ROM (12 cm)
    ISBN 3446411917 ; 9783446411913
    Database Library catalogue of the German National Library of Science and Technology (TIB), Hannover

    More links

    Kategorien

  10. Article ; Online: Caregivers' and physicians' attitudes to rotigotine transdermal patch versus oral Parkinson's disease medication: an observational study.

    Sieb, Jörn Peter / Themann, Peter / Warnecke, Tobias / Lauterbach, Thomas / Berkels, Reinhard / Grieger, Frank / Lorenzl, Stefan

    Current medical research and opinion

    2015  Volume 31, Issue 5, Page(s) 967–974

    Abstract: Objective: To provide real-world data on caregiver and physician perceptions of the advantages and disadvantages of rotigotine transdermal patch (Neupro * ) versus oral Parkinson's Disease (PD) medication.: Methods: Cross-sectional, non- ... ...

    Abstract Objective: To provide real-world data on caregiver and physician perceptions of the advantages and disadvantages of rotigotine transdermal patch (Neupro * ) versus oral Parkinson's Disease (PD) medication.
    Methods: Cross-sectional, non-interventional study in routine clinical practice in Germany (NCT01330290). Patients had PD with documented need for care, and had received rotigotine transdermal patch as add-on to oral PD treatment for ≥1 month. Caregivers/nurses and physicians assessed rotigotine transdermal patch versus oral PD medications using questionnaires. Specific questions regarding the possible benefits of transdermal application were asked and comprised questions on: swallowing dysfunction, nausea/vomiting, monitoring therapy, once daily application, application independently from meals, application to sleeping patients, caregiving efforts (caregivers only) and clinical aspects (physicians only). Each question was assessed on a 5 point scale ranging from -2 (major disadvantage) to 2 (major advantage) compared with oral treatment. Primary outcomes were mean total scores of all questions for caregivers/nurses and physicians who provided responses for ≥4 questions. As there are no validated tools to assess physician/caregiver preference in the PD setting, there is no reference against which the current findings can be compared; this study serves to pilot the questionnaires.
    Results: Questionnaire responses from 128 caregivers/nurses and 41 physicians were documented for 147 patients. One hundred (68%) patients had a caregiving family member; 40 (27%) were cared for by a nurse. Mean PD duration was 8.2 (SD 6.3) years; 136 (93%) patients were taking levodopa. Mean total score of caregivers'/nurses' questionnaires was 1.32 (SD 0.67) and of physicians' questionnaires was 1.46 (0.32) indicating a perceived advantage of rotigotine transdermal patch over oral PD therapy. Mean scores for individual questions were in the range 1.03-1.54 for caregivers/nurses and 1.15-1.87 for physicians. When given a choice about rationale to prescribe, physicians cited pharmaceutical form (patch) in 139 (95%) cases and active agent (rotigotine) in 89 (61%) cases.
    Conclusion: Caregivers/nurses and physicians perceived advantages with rotigotine transdermal patch compared to an oral PD medication as add-on therapy in patients with PD; advantages were observed in aspects of medical treatment as well as in everyday situations of caregiving of PD patients.
    MeSH term(s) Administration, Cutaneous ; Administration, Oral ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Caregivers/statistics & numerical data ; Cross-Sectional Studies ; Dopamine Agonists/administration & dosage ; Dopamine Agonists/therapeutic use ; Female ; Germany ; Humans ; Levodopa/therapeutic use ; Male ; Middle Aged ; Parkinson Disease/drug therapy ; Physicians/statistics & numerical data ; Pilot Projects ; Surveys and Questionnaires ; Tetrahydronaphthalenes/administration & dosage ; Tetrahydronaphthalenes/therapeutic use ; Thiophenes/administration & dosage ; Thiophenes/therapeutic use ; Transdermal Patch ; Young Adult
    Chemical Substances Dopamine Agonists ; Tetrahydronaphthalenes ; Thiophenes ; Levodopa (46627O600J) ; rotigotine (87T4T8BO2E)
    Language English
    Publishing date 2015-05
    Publishing country England
    Document type Clinical Trial ; Comparative Study ; Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 80296-7
    ISSN 1473-4877 ; 0300-7995
    ISSN (online) 1473-4877
    ISSN 0300-7995
    DOI 10.1185/03007995.2015.1030376
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top